These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9037054)

  • 1. Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2.
    Weishaupt A; Gold R; Gaupp S; Giegerich G; Hartung HP; Toyka KV
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1338-43. PubMed ID: 9037054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope.
    Stienekemeier M; Falk K; Rötzschke O; Weishaupt A; Schneider C; Toyka KV; Gold R; Strominger JL
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13872-7. PubMed ID: 11717443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis.
    Mausberg AK; Szepanowski F; Odoardi F; Flügel A; Kleinschnitz C; Stettner M; Kieseier BC
    J Neuroinflammation; 2018 Aug; 15(1):217. PubMed ID: 30068351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN.
    Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP
    Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
    Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of TNF-alpha in high-dose antigen therapy in experimental autoimmune neuritis: inhibition of TNF-alpha by neutralizing antibodies reduces T-cell apoptosis and prevents liver necrosis.
    Weishaupt A; Gold R; Hartung T; Gaupp S; Wendel A; Brück W; Toyka KV
    J Neuropathol Exp Neurol; 2000 May; 59(5):368-76. PubMed ID: 10888366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New minimum length requirement for a T cell epitope for experimental allergic neuritis.
    Olee T; Powell HC; Brostoff SW
    J Neuroimmunol; 1990 May; 27(2-3):187-90. PubMed ID: 1692033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis.
    Gregorian SK; Clark L; Heber-Katz E; Amento EP; Rostami A
    Cell Immunol; 1993 Sep; 150(2):298-310. PubMed ID: 7690307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide 53-78 of myelin P2 protein is a T cell epitope for the induction of experimental autoimmune neuritis.
    Rostami A; Gregorian SK
    Cell Immunol; 1991 Feb; 132(2):433-41. PubMed ID: 1703049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative histology of experimental allergic neuritis induced with minimum length neuritogenic peptides by adoptive transfer with sensitized cells or direct sensitization.
    Powell HC; Olee T; Brostoff SW; Mizisin AP
    J Neuropathol Exp Neurol; 1991 Sep; 50(5):658-74. PubMed ID: 1716669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of experimental allergic neuritis in the immune suppressed host.
    Hahn AF; Feasby TE; Lovgren D; Wilkie L
    Acta Neuropathol; 1993; 86(6):596-601. PubMed ID: 7508670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed-type hypersensitivity response in experimental autoimmune neuritis treated with peptide-coupled spleen cells.
    Gregorian SK; Rostami A
    J Neuroimmunol; 1994 Apr; 51(1):69-75. PubMed ID: 7512578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease.
    Linington C; Mann A; Izumo S; Uyemura K; Suzuki M; Meyermann R; Wekerle H
    J Immunol; 1986 Dec; 137(12):3826-31. PubMed ID: 2431045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of experimental allergic neuritis with P2-reactive T-cell lines.
    Rostami A; Burns JB; Brown MJ; Rosen J; Zweiman B; Lisak RP; Pleasure DE
    Cell Immunol; 1985 Apr; 91(2):354-61. PubMed ID: 2581699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta.
    Jung S; Krämer S; Schluesener HJ; Hünig T; Toyka K; Hartung HP
    J Immunol; 1992 Jun; 148(12):3768-75. PubMed ID: 1376340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of experimental allergic neuritis by an antibody to the intracellular adhesion molecule ICAM-1.
    Archelos JJ; Mäurer M; Jung S; Toyka KV; Hartung HP
    Brain; 1993 Oct; 116 ( Pt 5)():1043-58. PubMed ID: 7693297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of severe experimental autoimmune neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein.
    Rostami A; Gregorian SK; Brown MJ; Pleasure DE
    J Neuroimmunol; 1990 Dec; 30(2-3):145-51. PubMed ID: 1699975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with P2 protein peptide 57-81 by nasal route is effective in Lewis rat experimental autoimmune neuritis.
    Zou LP; Zhu J; Deng GM; Levi M; Wahren B; Diab A; Hillert J; Link H
    J Neuroimmunol; 1998 May; 85(2):137-45. PubMed ID: 9630162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticosteroids modulate antigen-induced T cell apoptosis in experimental autoimmune neuritis and cause T cell proliferation in situ.
    Weishaupt A; Schönrock LM; Stienekemeier M; Toyka KV; Gold R
    Acta Neuropathol; 2001 Jul; 102(1):75-82. PubMed ID: 11547954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of experimental autoimmune neuritis in Lewis rats by oral application of myelin antigens.
    Gaupp S; Hartung HP; Toyka K; Jung S
    J Neuroimmunol; 1997 Nov; 79(2):129-37. PubMed ID: 9394785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.